Previous studies have indicated an inhibitory effect of the genetic modifier TGF-β on CFTR; therefore, Kabir et al. investigated whether TGF-β-based inhibition of CFTR expression could be affected by miRNAs isolated from BAL-derived exosomes of CF patients. Here, TGFB1 is linked to cystic fibrosis.